Crossref
Identification of a series of 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amines, as a new class of G-protein-coupled receptor kinase 2 and 5 inhibitor
Receptors & Clinical Investigation · 2014
DOI: 10.14800/rci.100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Receptors & Clinical Investigation, 2014.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2014). Identification of a series of 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amines, as a new class of G-protein-coupled receptor kinase 2 and 5 inhibitor. Receptors & Clinical Investigation. https://doi.org/10.14800/rci.100
Vancouver
Identification of a series of 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amines, as a new class of G-protein-coupled receptor kinase 2 and 5 inhibitor. Receptors & Clinical Investigation. 2014. doi:10.14800/rci.100
BibTeX
@article{euvimed2014,
title = {Identification of a series of 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amines, as a new class of G-protein-coupled receptor kinase 2 and 5 inhibitor},
journal = {Receptors & Clinical Investigation},
year = {2014},
doi = {10.14800/rci.100}
}
EUVIMED